Literature DB >> 26962901

Stroke and t-PA--Triggering New Paradigms of Care.

Stephanie J Snow1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26962901      PMCID: PMC5331951          DOI: 10.1056/NEJMp1514696

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  4 in total

1.  Should physicians give tPA to patients with acute ischemic stroke? Against: and just what is the emperor of stroke wearing?

Authors:  J R Hoffman
Journal:  West J Med       Date:  2000-09

2.  Cerebral vascular diseases: their significance, diagnosis and present treatment, including the selective use of anticoagulant substances.

Authors:  I S WRIGHT; E McDEVITT
Journal:  Ann Intern Med       Date:  1954-10       Impact factor: 25.391

3.  Stroke: 'time is brain' after stroke, regardless of age and severity.

Authors:  Heinrich J Audebert; Jan Sobesky
Journal:  Nat Rev Neurol       Date:  2014-10-21       Impact factor: 42.937

4.  Tissue plasminogen activator for acute ischemic stroke.

Authors: 
Journal:  N Engl J Med       Date:  1995-12-14       Impact factor: 91.245

  4 in total
  10 in total

1.  Combination of puerarin and tanshinone IIA alleviates ischaemic stroke injury in rats via activating the Nrf2/ARE signalling pathway.

Authors:  Qing Miao; Ruihai Wang; Xiaoxin Sun; Song Du; Limei Liu
Journal:  Pharm Biol       Date:  2022-12       Impact factor: 3.889

2.  O-GlcNAc Transferase (OGT) Protects Cerebral Neurons from Death During Ischemia/Reperfusion (I/R) Injury by Modulating Drp1 in Mice.

Authors:  Jingru Zhao; Lipeng Dong; Tiantian Huo; Jinming Cheng; Xiaojuan Li; Xiaojuan Huangfu; Sujuan Sun; Hebo Wang; Litao Li
Journal:  Neuromolecular Med       Date:  2021-10-27       Impact factor: 4.103

3.  Cannabinoid CB1 receptor agonist ACEA alleviates brain ischemia/reperfusion injury via CB1-Drp1 pathway.

Authors:  Shuai Yang; Bin Hu; Zongming Wang; Changming Zhang; Haosen Jiao; Zhigang Mao; Liguang Wei; Ji Jia; Jingling Zhao
Journal:  Cell Death Discov       Date:  2020-10-12

4.  KCNQ1OT1 promotes autophagy by regulating miR-200a/FOXO3/ATG7 pathway in cerebral ischemic stroke.

Authors:  Shijia Yu; Mingjun Yu; Xin He; Lulu Wen; Zhongqi Bu; Juan Feng
Journal:  Aging Cell       Date:  2019-04-03       Impact factor: 9.304

5.  Cerebrolysin Ameliorates Focal Cerebral Ischemia Injury Through Neuroinflammatory Inhibition via CREB/PGC-1α Pathway.

Authors:  Xin Guan; Yunjie Wang; Guoyin Kai; Shunyi Zhao; Tingyu Huang; Youzhen Li; Yuan Xu; Luyong Zhang; Tao Pang
Journal:  Front Pharmacol       Date:  2019-10-22       Impact factor: 5.810

Review 6.  Emerging Role of Ferroptosis in the Pathogenesis of Ischemic Stroke: A New Therapeutic Target?

Authors:  Zhong-Qi Bu; Hai-Yang Yu; Jue Wang; Xin He; Yue-Ran Cui; Jia-Chun Feng; Juan Feng
Journal:  ASN Neuro       Date:  2021 Jan-Dec       Impact factor: 4.146

7.  Profile and Functional Prediction of Plasma Exosome-Derived CircRNAs From Acute Ischemic Stroke Patients.

Authors:  Jie Yang; Junli Hao; Yapeng Lin; Yijia Guo; Ke Liao; Min Yang; Hang Cheng; Ming Yang; Kejie Chen
Journal:  Front Genet       Date:  2022-03-14       Impact factor: 4.599

8.  Novel insight into circular RNA HECTD1 in astrocyte activation via autophagy by targeting MIR142-TIPARP: implications for cerebral ischemic stroke.

Authors:  Bing Han; Yuan Zhang; Yanhong Zhang; Ying Bai; Xufeng Chen; Rongrong Huang; Fangfang Wu; Shuo Leng; Jie Chao; John H Zhang; Gang Hu; Honghong Yao
Journal:  Autophagy       Date:  2018-07-20       Impact factor: 16.016

9.  SOD2 Mediates Curcumin-Induced Protection against Oxygen-Glucose Deprivation/Reoxygenation Injury in HT22 Cells.

Authors:  Yuqing Wang; Yuanyuan Zhang; Liang Yang; Jin Yuan; Ji Jia; Shuai Yang
Journal:  Evid Based Complement Alternat Med       Date:  2019-09-29       Impact factor: 2.629

10.  SNHG12 inhibits oxygen‑glucose deprivation‑induced neuronal apoptosis via the miR‑181a‑5p/NEGR1 axis.

Authors:  Yangtian Yan; Li Chen; Jiajun Zhou; Liquan Xie
Journal:  Mol Med Rep       Date:  2020-08-24       Impact factor: 2.952

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.